InspireMD (NSPR) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free NSPR Stock Alerts $1.89 +0.04 (+2.16%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInspireMD, Inc. (NSPR)ca.finance.yahoo.com - April 26 at 2:18 AMInspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 24 at 2:30 AMInspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.commarketbeat.com - April 8 at 2:24 AMInspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 3 at 9:09 AMInspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 3 at 8:59 AMPope Francis appeals for Gaza cease-fire and Russia-Ukraine prisoner swap in Easter Sunday prayersmsn.com - March 31 at 9:28 PMInspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024globenewswire.com - March 26 at 7:00 AMInspireMD (NYSE:NSPR) Releases Earnings Results, Beats Expectations By $0.04 EPSmarketbeat.com - March 7 at 10:29 AMInspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 6 at 4:00 PMNSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 6 at 2:00 PMInspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 6 at 7:00 AMPreview: InspireMD's Earningsbenzinga.com - March 5 at 2:31 PMInspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6thglobenewswire.com - February 28 at 7:00 AMNSPR Mar 2024 7.500 callca.finance.yahoo.com - February 21 at 4:15 PMStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)marketbeat.com - February 4 at 1:30 AMInspireMD Announces CE Mark Recertification Under MDRmsn.com - February 1 at 8:18 AMInspireMD Secures CE Mark Recertification Under New EU Standardsmsn.com - February 1 at 8:18 AMWe're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wiselyfinance.yahoo.com - January 23 at 9:18 AMInspireMD (NSPR) Price Target Increased by 11.49% to 4.95msn.com - November 27 at 9:57 PMDown -24.61% in 4 Weeks, Here's Why InspireMD, Inc. (NSPR) Looks Ripe for a Turnaroundmsn.com - November 23 at 2:04 PMInspireMD earnings: here's what Wall Street expectsmarkets.businessinsider.com - November 6 at 8:04 AMInspireMD GAAP EPS of -$0.15 misses by $0.01, revenue of $1.56M beats by $0.06Mmsn.com - November 6 at 8:04 AMInspireMD Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 6 at 8:04 AMInspireMD Q3 2023 Earnings Previewmsn.com - November 3 at 12:58 PMInspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23markets.businessinsider.com - November 1 at 5:58 PMPiper Sandler Remains a Buy on InspireMD (NSPR)markets.businessinsider.com - September 25 at 8:24 AMInspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in Polandfinance.yahoo.com - September 22 at 8:58 AMInspireMD (NSPR) Price Target Increased by 5.45% to 4.44msn.com - August 31 at 7:06 PMHere's Why We're Not Too Worried About InspireMD's (NASDAQ:NSPR) Cash Burn Situationfinance.yahoo.com - August 16 at 9:54 AMInspireMD (NSPR) Price Target Increased by 6.45% to 4.21msn.com - August 3 at 4:06 AMInspireMD (NSPR) Price Target Decreased by 18.42% to 3.95msn.com - July 6 at 10:06 AMInspireMD, Inc.: InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trialfinanznachrichten.de - June 26 at 1:32 PMInspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trialfinance.yahoo.com - June 26 at 8:32 AMNSPR - InspireMD, Inc.ca.finance.yahoo.com - June 17 at 4:13 PMPiper Sandler Initiates Coverage of InspireMD (NSPR) with Overweight Recommendationmsn.com - June 14 at 12:08 PMInspireMD Announces "12 Days of Carotid Stenting" Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialistsbenzinga.com - November 28 at 6:43 PMInspireMD Third Quarter 2022 Earnings: Beats Expectationsuk.finance.yahoo.com - November 11 at 8:46 AMInspireMD, Inc. (NSPR) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 8 at 4:56 PMInspireMD, Inc.: InspireMD Reports Third Quarter 2022 Financial Results and Provides Business Updatefinanznachrichten.de - November 8 at 11:56 AMInspireMD Reports Third Quarter 2022 Financial Results and Provides Business Updatetechnews.tmcnet.com - November 8 at 11:56 AMEarnings Scheduled For November 8, 2022msn.com - November 8 at 6:56 AMInspireMD Announces Presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Conference | Morningstarmorningstar.com - September 15 at 2:13 AMNAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Developmentfinance.yahoo.com - September 8 at 12:22 PMInspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Updatefinance.yahoo.com - August 2 at 8:13 AMInspireMD Provides Highlights from Recent Presentations and Live Case Transmission at LINC 2022finance.yahoo.com - June 9 at 10:55 AMInspireMD's CGuard(TM) Embolic Prevention Stent System to be Featured in Clinical Presentations and a Live Case Transmission at LINC 2022stockhouse.com - June 3 at 1:05 PMInspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 10 at 5:31 PMInspireMD Reports First Quarter 2022 Financial Results and Business Updatestockhouse.com - May 10 at 12:31 PMInspireMD Q1 2022 Earnings Previewseekingalpha.com - May 9 at 4:29 PMInspireMD Reports Fourth Quarter and Year-End 2021 Financial Resultsfinance.yahoo.com - March 8 at 9:38 AM Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). NSPR Media Mentions By Week NSPR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼0.590.40▲Average Medical News Sentiment NSPR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼10▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SRTS News Today AMIX News Today APYX News Today SEPA News Today XAIR News Today ICCM News Today CTSO News Today CTCX News Today NVNO News Today LUCD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
